CAAS Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-29,000	Closed	-$613K	–	659
2021 Q2	$613K	Hold	29,000	–	–	0.01%	389
2021 Q1	$813K	Buy	+29,000	New	+$813K	0.01%	466